课题基金 / 基金详情

Mechanisms that regulate chromosomal stability through the ubiquitin lipase activity of BRCA1

Mechanisms that regulate chromosomal stability through the ubiquitin lipase activity of BRCA1
通过 BRCA1 泛素脂肪酶活性调节染色体稳定性的机制
批准号:
16591280
负责人:
OHTA Tomohiko
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

OHTA Tomohiko的其他基金

相似基金

相关文献

中文摘要
翻译
我在2001年发现BRCA1与BARD1构成了RING异二聚体型泛素连接酶。在这项研究中,我进一步研究了 BRCA1 的底物,以阐明该活性如何促进 BRCA1 维持染色体稳定性的能力。我通过我们最初的筛选方法识别了几种基材。其中我在2004年研究了核磷蛋白/B23(NPM)。BRCA1-BARD1在体内和体外与NPM相互作用并被多泛素化。多泛素化是非传统的Lys-6连接类型,因此NPM不会因修饰而降解,而是稳定化。当 NPM 实际上在体内泛素化时,BRCA1-BARD1 和 NPM 在有丝分裂过程中共定位于染色体表面。我认为 NPM 泛素化的缺乏可能是 BRCA1 缺陷引起的中心体过度扩增和非整倍性的基础。接下来,我在 2005 年分析了另一种候选底物 RPB8。BRCA1-BARD1 在体内和体外与 RPB8 相互作用,并对 RPB8 进行多聚泛素化。在稳定表达 FLAG 标签的 RPB8 的 HeLa 细胞中,紫外线照射 10 分钟后观察到 RPB8 的泛素化,并且这种泛素化被 siRNA 敲低 BRCA1 所消除。有趣的是,稳定表达泛素抗性 RPB8 突变体的 HeLa 细胞表现出紫外线超敏性。结果表明,BRCA1 通过 RPB8 泛素化进行转录偶联 DNA 修复来调节染色体稳定性。
英文摘要
I have discovered in 2001 that BRCA1 constituted a RING heterodimer type ubiquitin ligase with BARD1. In this study I further investigated the substrates of BRCA1 to elacidate how the activity contributed the BRCA1's ability to maintain the chromosomal stability. I identified several substrates by our original screen methods. Among them I have investigated nucleophosmin/B23 (NPM) in 2004. BRCA1-BARD1 interacted with and polyubiquitinated NPM in vivo and in vitro. The polyubiquitination was non-traditional Lys-6-linked type, and therefore NPM was not degraded by the modification and instead stabilized. BRCA1-BARD1 and NPM were co-localized over the chromosomal surface during mitosis when NPM was actually ubiquitinated in vivo. I propose the lack of NPM ubiquitination could be the basis of centrosome hyper amplification and aneuploidy caused by BRCA1 deficiency. I next analyzed another candidate substrate, RPB8, in 2005. BRCA1-BARD1 interacted with and polyubiquitinated RPB8 in vivo and in vitro. The ubiquitination of RPB8 was observed 10 minutes after UV irradiation in HeLa cells stably expressing FLAG-tagged RPB8, and this ubiquitination was abolished by BRCA1 knockdown by siRNA. Interestingly HeLa cells stably expressing ubiquitin-resistant RPB8 mutant exhibited UV hypersensitivity. The results suggested that BRCA1 regulates chromosomal stability by transcription-coupled DNA repair through ubiquitination of RPB8.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Breast tumor suppressor BRCA1
乳腺肿瘤抑制因子 BRCA1
DOI: --
发表时间: 2004
期刊: New Horizon Med. (Japanese) 36(4)
影响因子: --
作者: [Ohta T, Hayami R, Wu W, Fukuda M.]
通讯作者: Fukuda M.
DOI: 10.1038/ncb1172
发表时间: 2004-10-01
期刊: NATURE CELL BIOLOGY
影响因子: 21.3
作者: [Hu, J, McCall, CM, Xiong, Y]
通讯作者: Xiong, Y
Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
CDK2 下调 BRCA1-BARD1 泛素连接酶。
DOI: --
发表时间: 2005
期刊: Cancer Res. 65
影响因子: --
作者: [Hayami R, Sato K, Wu W, Nishikawa T, Hiroi J, Ohtani-Kaneko R, Fukuda M, Ohta T.]
通讯作者: Ohta T.
DOI: 10.1074/jbc.c400169200
发表时间: 2004-07-23
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Sato, K, Hayami, R, Ohta, T]
通讯作者: Ohta, T
11
    A study of mechanism underlying carcinogenesis promoted by estrogen receptor in BRCA1 deficient cells
    • 批准号:
      16K15712
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      OHTA Tomohiko
    • 依托单位:
    Unravelling the mechanism of ovarian carcinogenesis caused by BRCA1 depletion and estrogen action
    • 批准号:
      26670730
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      OHTA Tomohiko
    • 依托单位:
    Functional analysis of BRCA1 as the molecular basis of breast cancer therapy
    • 批准号:
      26290042
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2014
    • 负责人:
      OHTA Tomohiko
    • 依托单位:
    Research on the breast cancer chemotherapy targeting synthetic lethality caused by the factors in the DNA damage repair pathways.
    • 批准号:
      23300358
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $14.06万
    • 财政年份:
      2011
    • 负责人:
      OHTA Tomohiko
    • 依托单位:
    国内基金
    海外基金
    靶向NMD调控BARD1异常剪接体衰变在MDS中的机制研究
    • 批准号:
      82300163
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      王路
    • 依托单位:
    BARD1胚系突变在乳腺癌DNA损伤应答中的作用及潜在临床意义
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      姚璐
    • 依托单位:
    BARD1识别损伤的染色质并启动同源重组修复的机制研究
    • 批准号:
      32100456
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      黄艳
    • 依托单位:
    缺氧诱导的miR-210靶向BARD1调控细胞周期参与子宫内膜异位症的发展
    • 批准号:
      81671435
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2016
    • 负责人:
      张松英
    • 依托单位: